The Winter laboratory at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, is recruiting a postdoc-level researcher to develop novel strategies to target undruggable proteins for the treatment of cancer.
How can we determine the mechanism of action of hundreds of small-molecules in an unbiased manner to guide the innovation and characterization of next-generation anti-cancer therapeutics?
We hypothesize that a much larger fraction of the proteome is amenable to novel paradigms in drug discovery. The successful applicant will work on these questions as part of- and supported by a multi-disciplinary research team at CeMM in Vienna, and in close contact with our partners at Pfizer in Cambridge / US.
At this vibrant interface between academia and industry, the successful candidate has a unique opportunity to achieve a palpable translational impact.
The candidate should have a scientific track record (including at least one first author publication) in the field of proteomics and deep know-how either in the generation (wet-lab) or the analysis (dry-lab) of proteomics / mass spectrometry data.
A track record in supervising students or technical assistants would be an asset. The working language at CeMM is English, and excellent written and oral communication skills as well as high accuracy, reliability and excellent interpersonal and organizational skills are a requirement.
The working language is English. CeMM has been ranked by The Scientist as one of the Best Places to Work Academia worldwide (link : ).
In the past 3 years CeMM groups published numerous ground-breaking studies in prestigious journals such as Science, Cell, Nature, New England Journal of Medicine, Nature Immunology, Immunity etc.
CeMM is located within the medical campus of Vienna and operates several technology platforms (chemical biological screening, proteomics, metabolomics, next-generation sequencing) as well as extensive bioinformatics infrastructure.